698350-53-7

Usage

Uses

Used in Pharmaceutical Industry:
(4S,4'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) serves as a pharmaceutical intermediate, playing a crucial role in the synthesis of various medicinal compounds. Its unique structure allows it to be a key component in the development of new drugs.
Used in Research and Development:
In the realm of research and development, (4S,4'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) acts as a synthetic building block for the production of a wide range of compounds. Its distinctive properties make it an essential tool for creating novel materials and exploring new chemical pathways.
Used in Medicinal Chemistry and Drug Discovery:
(4S,4'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) holds potential applications in medicinal chemistry and drug discovery due to its distinctive chemical structure. It can be utilized to design and develop new therapeutic agents, contributing to advancements in healthcare and medicine.

Upstream product

• 100-39-0 benzyl bromide 
• 499786-37-7 1,1‐bis[(4S)‐4‐isopropyl‐4,5‐dihydrooxazol‐2‐yl]ethane 
• 2026-48-4 (S)-valinol 

Relevant academic research and scientific papers

Chiral stimuli-responsive metallo-supramolecular assembly induced by CuII/CuIredox change

We investigated the selective formation of homoleptic and heteroleptic metal complexes controlled by means of the chiral molecular instruction of the ligand and the coordination geometry of the metal. Our results showed that chiral self-recognition or self-discrimination may be induced by the CuI/CuII redox transition using cyclic voltammetry. The further use of chiral ditopic ligands led to metallo-supramolecular copolymers with stimuli-responsive controlled arrangement.

Highly recyclable self-supported chiral catalysts for the enantioselective α-hydrazination of β-ketoesters

Multitopic chiral copper complexes based on bis(oxazoline) have been applied in the enantioselective α-hydrazination of β-ketoesters. High yields and excellent enantioselectivities were obtained. Furthermore, the catalytic systems have been recovered in u

Ligand-accelerated asymmetric [1,2]-Stevens rearrangment of sulfur ylides via decomposition of diazomalonates catalyzed by chiral bisoxazoline/copper complex

The first example of catalytic asymmetric [1,2]-Stevens rearrangement reaction of 1,3-oxathiolanes with diazomalonates has been developed and up to 90% ee is achieved by the bisoxazoline 4e/ copper(II) triflate [Cu(OTf) 2] complex.